Supplemental Material from Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell AnalysisKiyomi Shitaoka, Atsushi Muraguchi, Hiroshi Hamana et al.|Unknown|2023Cited by 0
Data from Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell AnalysisKiyomi Shitaoka, Atsushi Muraguchi, Hiroshi Hamana et al.|Unknown|2023Cited by 0
Supplemental Material from Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell AnalysisKiyomi Shitaoka, Atsushi Muraguchi, Atsushi Tanemura et al.|Unknown|2023Cited by 0
Data from Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell AnalysisKiyomi Shitaoka, Atsushi Muraguchi, Hiroshi Hamana et al.|Unknown|2023Cited by 0
An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in SchizophreniaKotaro Sakamoto, Yukio Ago, Zihao Jin et al.|Biological and Pharmaceutical Bulletin|2026Cited by 0